A Phase III Randomized, Placebo-Controlled Study of Sorafenib in Patients with Advanced Hepatocellular carcinoma

  • Koch, Alvaro (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date8/1/057/31/07